retatrutide 2 week results Safety, Side Effects & Provider Use The next installment of the

D., Massry S

Several factors affect how tirzepatide moves through the body

your prescriber can safely adjust to find your optimal therapeutic level

Mounjaro ranked second, prescribed to nearly 1% of adults, followed closely by Wegovy, Zepbound, and Saxenda together at around 0.7%

Acknowledgements: The authors would like to thank Sarah Minter and Benjamin Smith for comments on an early version of the manuscript

Vomiting Frequency: 11% of trial participants Onset: 2-6 hours post-injection Duration: Episodes typically last 1-2 hours Severity: Usually occurs early in treatment Vomiting is less common than nausea but can occur, especially with large meals during early adaptation